Paper25280219
SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells.
Li L and 22 others. Cell Stem Cell, 2014. Cited by 185 papers, by iCite.
Cite this record
ConductScience Library. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Papers, record 25280219. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25280219
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Resistance, Neoplasm | Major topic |
| Gene Regulatory Networks | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Neoplastic Stem Cells | Major topic |
| Proto-Oncogene Proteins c-myc | Major topic |
| Sirtuin 1 | Major topic |
| fms-Like Tyrosine Kinase 3 | Major topic |
| Animals | |
| Antigens, CD34 | |
| Benzothiazoles | |
| Cell Proliferation | |
| Cell Survival | |
| Gene Duplication | |
| Gene Knockdown Techniques | |
| Humans | |
| Mice, SCID | |
| Phenylurea Compounds | |
| Protein Binding | |
| Thiolester Hydrolases | |
| Ubiquitin Thiolesterase |
Source PubMed
Grants10
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R00 CA184411 | NCI NIH HHS | United States | K99CA184411 | PubMed and NIH | NIH RePORTER |
| P30CA033572 | NCI NIH HHS | United States | P30CA033572 | PubMed and NIH | NIH RePORTER |
| R01 CA178387 | NCI NIH HHS | United States | R01CA178387 | PubMed and NIH | NIH RePORTER |
| K99 CA184411 | NCI NIH HHS | United States | K99CA184411 | PubMed and NIH | NIH RePORTER |
| R01 CA095684 | NCI NIH HHS | United States | R01CA095684 | PubMed and NIH | NIH RePORTER |
| R01 CA143421 | NCI NIH HHS | United States | R01CA143421 | PubMed and NIH | NIH RePORTER |
| K99CA184411 | NCI NIH HHS | United States | K99CA184411 | PubMed and NIH | NIH RePORTER |
| R01 CA95684 | NCI NIH HHS | United States | R01CA095684 | PubMed and NIH | NIH RePORTER |
| P30 CA033572 | NCI NIH HHS | United States | P30CA033572 | PubMed and NIH | NIH RePORTER |
| R00CA184411 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 25280212 | A knockout Combo: eradicating AML Stem Cells with TKI plus SIRT1 inhibition. | https://conductscience.org/library/papers/25280212 |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17686054 | Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells. | Br J Haematol | 2007 | https://conductscience.org/library/papers/17686054 | PubMed |
| 2 | 23630229 | Sirt1 ablation promotes stress-induced loss of epigenetic and genomic hematopoietic stem and progenitor cell maintenance. | J Exp Med | 2013 | https://conductscience.org/library/papers/23630229 | PubMed |
| 3 | 22417203 | Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22417203 | PubMed |
| 4 | 19441904 | Sirtuin inhibitors. | Expert Opin Ther Pat | 2009 | https://conductscience.org/library/papers/19441904 | PubMed |
| 5 | 18851829 | Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. | Mol Cell | 2008 | https://conductscience.org/library/papers/18851829 | PubMed |
| 6 | 19132007 | How does SIRT1 affect metabolism, senescence and cancer? | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19132007 | PubMed |
| 7 | 22207684 | The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells. | Haematologica | 2012 | https://conductscience.org/library/papers/22207684 | PubMed |
| 8 | 20705759 | FLT3 as a therapeutic target in AML: still challenging after all these years. | Blood | 2010 | https://conductscience.org/library/papers/20705759 | PubMed |
| 9 | 22190494 | The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22190494 | PubMed |
| 10 | 20404136 | Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia. | Blood | 2010 | https://conductscience.org/library/papers/20404136 | PubMed |
| 11 | 11021753 | The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. | Leukemia | 2000 | https://conductscience.org/library/papers/11021753 | PubMed |
| 12 | 22511496 | Recent advances in acute myeloid leukemia stem cell biology. | Haematologica | 2012 | https://conductscience.org/library/papers/22511496 | PubMed |
| 13 | 22064349 | Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. | Leukemia | 2012 | https://conductscience.org/library/papers/22064349 | PubMed |
| 14 | 23429453 | Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6. | Sci Rep | 2013 | https://conductscience.org/library/papers/23429453 | PubMed |
| 15 | 18835033 | Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18835033 | PubMed |
| 16 | 22878824 | NCCN Clinical Practice Guidelines Acute myeloid leukemia. | J Natl Compr Canc Netw | 2012 | https://conductscience.org/library/papers/22878824 | PubMed |
| 17 | 23243270 | Multiplexed mAbs: a new strategy in preclinical time-domain imaging of acute myeloid leukemia. | Blood | 2013 | https://conductscience.org/library/papers/23243270 | PubMed |
| 18 | 15084694 | Prognostically useful gene-expression profiles in acute myeloid leukemia. | N Engl J Med | 2004 | https://conductscience.org/library/papers/15084694 | PubMed |
| 19 | 18309032 | An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML. | Blood | 2008 | https://conductscience.org/library/papers/18309032 | PubMed |
| 20 | 11672523 | hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. | Cell | 2001 | https://conductscience.org/library/papers/11672523 | PubMed |
Cited by144
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882913 | PODXL2 Expression Is Associated with Inferior Survival, Adverse-Risk Features, and Distinct Transcriptional Programs in Acute Myeloid Leukemia. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882913 | PubMed |
| 42848173 | Arbutin as a promising cardioprotective anticancer adjuvant with doxorubicin in solid Ehrlich carcinoma through targeting NEK7-dependent inflammasome/SIRT1/caspase-3/oxidative stress pathways. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42848173 | PubMed |
| 42512320 | Can Disruption of Circadian Rhythms Be Linked to Radiation-Induced Acute Myeloid Leukaemia? | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512320 | PubMed |
| 42004278 | CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy. | RNA Nanomed | 2025 | https://conductscience.org/library/papers/42004278 | PubMed |
| 41942609 | A novel microprotein L3EMP triggers lung adenocarcinoma progression by catalysing the deubiquitination of SIRT1. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41942609 | PubMed |
| 41858737 | Mitochondrial metabolism in cancer stem cells (CSCs): molecular and diagnostic implications. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/41858737 | PubMed |
| 41471781 | Antileukemic Potential of Sodium Caseinate in Cytarabine-Resistant HL60-CR50 Human Leukemia Cells. | Molecules | 2025 | https://conductscience.org/library/papers/41471781 | PubMed |
| 40588567 | SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cells. | Leukemia | 2025 | https://conductscience.org/library/papers/40588567 | PubMed |
| 40510356 | Drug repurposing of fostamatinib against cancer via potential cytotoxicity and immune checkpoint regulation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40510356 | PubMed |
| 40299922 | IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming. | Elife | 2025 | https://conductscience.org/library/papers/40299922 | PubMed |
| 40149343 | The Role of the Sirtuin Family Histone Deacetylases in Acute Myeloid Leukemia-A Promising Road Ahead. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40149343 | PubMed |
| 40034124 | Key roles of ubiquitination in regulating critical regulators of cancer stem cell functionality. | Genes Dis | 2025 | https://conductscience.org/library/papers/40034124 | PubMed |
| 39907078 | Regulation of Stem Cell Function by NAD. | Physiology (Bethesda) | 2025 | https://conductscience.org/library/papers/39907078 | PubMed |
| 39497328 | IGF2BP3-dependent N6-methyladenosine modification of USP49 promotes carboplatin resistance in retinoblastoma by enhancing autophagy via regulating the stabilization of SIRT1. | Kaohsiung J Med Sci | 2024 | https://conductscience.org/library/papers/39497328 | PubMed |
| 39376992 | Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response. | Front Oncol | 2024 | https://conductscience.org/library/papers/39376992 | PubMed |
| 39356446 | The Role of SIRT1 in Leukemia. | Curr Treat Options Oncol | 2024 | https://conductscience.org/library/papers/39356446 | PubMed |
| 38909090 | Pivotal role of the endoplasmic reticulum stress-related XBP1s/miR-22/SIRT1 axis in acute myeloid leukemia apoptosis and response to chemotherapy. | Leukemia | 2024 | https://conductscience.org/library/papers/38909090 | PubMed |
| 38503523 | [Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | https://conductscience.org/library/papers/38503523 | PubMed |
| 38459421 | The MYC-NFATC2 axis maintains the cell cycle and mitochondrial function in acute myeloid leukaemia cells. | Mol Oncol | 2024 | https://conductscience.org/library/papers/38459421 | PubMed |
| 38434766 | Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia. | Cancer Drug Resist | 2024 | https://conductscience.org/library/papers/38434766 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25280219
GET https://conductscience.org/api/papers/v1/25280219/authors?page=2